Search

everythinglearnresearchcommunity

for

Search:↓

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Wnt-signaling is regulated differently in skin cells and immune responses during wound healing.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Dual TCR Treg cells are common in mouse tissues and vary by location.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Special cells can help regrow hair in alopecia areata.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.